Subscribe To
OTIC / Otonomy, Inc. (OTIC) CEO Dr. David Weber on Q1 2022 Results - Earnings Call Transcript
OTIC News
By InvestorPlace
November 29, 2022
Why Is Otonomy (OTIC) Stock Up 97% Today?
Otonomy (NASDAQ: OTIC ) stock is on the move Tuesday despite a lack of news from the biopharmaceutical company. Instead, it looks like traders have la more_horizontal
By Seeking Alpha
July 25, 2022
Otonomy, Inc. (OTIC) CEO Dave Weber on Q2 2022 Results - Earnings Call Transcript
Otonomy, Inc. (NASDAQ:OTIC ) Q2 2022 Earnings Conference Call July 25, 2022 4:30 PM ET Company Participants Robert Uhl - Managing Director, ICR Westwi more_horizontal
By Seeking Alpha
May 9, 2022
Otonomy, Inc. (OTIC) CEO Dr. David Weber on Q1 2022 Results - Earnings Call Transcript
Otonomy, Inc. (NASDAQ:OTIC ) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Robert Uhl - IR David Weber - President, CEO more_horizontal
By Seeking Alpha
April 4, 2022
Otonomy: Hearing Loss And Tinnitus Data In 2022
Data for OTO-413 in hearing loss is due early in Q2 2002. more_horizontal
By GlobeNewsWire
February 28, 2022
Otonomy to Participate in Two Upcoming Investor Conferences
SAN DIEGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative the more_horizontal
By GlobeNewsWire
February 28, 2022
Otonomy to Participate in Two Upcoming Investor Conferences
SAN DIEGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative the more_horizontal
By GlobeNewsWire
February 28, 2022
Otonomy to Participate in Two Upcoming Investor Conferences
SAN DIEGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative the more_horizontal